AstraZeneca is patenting (WO9932082) a way to help children and the elderly
take bulky tablets such as the asthma drug Zafirlukast, which is difficult to
swallow. Zeneca’s answer is to coat minuscule sugar or starch spheres less than
a millimetre wide with Zafirlukast and a polyvinylpyrrolidone binder. The
pellets are baked and sealed with another coating of a similar binder to conceal
the drug’s taste. The tiny pellets can then be sprinkled on food or in a drink
like sugar.
More from New Scientist
Explore the latest news, articles and features
Technology
Why full-fledged quantum computers might always be five years away
Comment
Technology
Quantum computers are starting to become useful as scientific tools
News
Technology
OpenAI’s hacking agent went rogue. Should we be worried?
News
Technology
China is trying to regulate relationships with AI – can it work?
News
Popular articles
Trending New Scientist articles